CMS has announced proposed revisions to its clinical trial policy, under which Medicare pays for certain items and services for beneficiaries involved in clinical trials. Among the proposed changes are renaming the policy as the Clinical Research Policy, requiring studies to publish their results, and paying for investigational clinical services if they are covered by Medicare outside the trial or are required under coverage with evidence development.
The proposal includes a 30-day comment period; CMS will publish the final national coverage determination no later than 60 days after the end of the comment period.
